Regeneron · 1 hour ago
Dir Development Program Management
Regeneron is a leading biotechnology company focused on developing innovative medicines. The Director of Development Program Management will provide operational leadership and direction to development programs, ensuring alignment with corporate goals while managing cross-functional teams and driving strategic initiatives.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Partners with the Global Program Head to drive strategic program teams (SPT) and sub teams by leading key governance meetings
Uses broad knowledge of drug development and project/program management coupled with leadership and problem-solving skills to align development teams around an integrated project/program plans, timelines and budgets based on program vision
Ensures efficient delivery of plans
Proposes and aligns annual program goals with program strategy and Regeneron’s corporate goals
Monitors progress against program goals and ensures accurate and timely reporting of program progress to management
Anticipates issues and program risks and drives timely development of risk management plans and issue resolution
Utilizes knowledge of industry trends to identify risks/threats/opportunities and translates these to actionable activities for the development teams
Able to leverage political savvy and awareness of team dynamics to effectively drive decision making and achieve desired outcomes
Is proficient in project management planning systems (MS Project, SharePoint) and tools/techniques
Understands how systems and tools can be leveraged to move the program and business forward
Effective and trusted communicator that will develop a proven track record across the organization
Works effectively with different styles and adapts approaches in a cross-functional matrix environment to drive results
Establishes a culture which promotes and encourages open communication, transparency, accountability and learning from mistakes
Is proficient at proactively identifying and critically analyzing potential problems that may affect the project, processes, or the team
Uses extensive industry and professional experience and knowledge to develop viable, long-term solutions to cross-functional, project, process, or team issues, driving alignment with impacted stakeholders
Proactively implements lessons learned/best practices across programs/TA and department to help other teams preempt or mitigate problems
Strengthens teams and continuously works to drive teams to be high performing and efficient
Ability to align team members towards a common goal through expertise with conflict management, self/social awareness, and diverse team dynamics
Qualification
Required
Bachelor's degree
12+ years of in-house pharmaceutical program management
Knowledge of the drug development process
Understanding of clinical trials
Excellent written, verbal, and interpersonal communication skills
Ability to effectively interact with all levels both internal and external to the company
Strong presentation and critical thinking skills
Exceptional organizational and time management skills
Ability to handle multiple projects and priorities
Ability to thrive in fast paced entrepreneurial organizations
Expert in dealing with ambiguity and uncertainty
Benefits
Health and wellness programs (including medical, dental, vision, life, and disability insurance)
Fitness centers
401(k) company match
Family support benefits
Equity awards
Annual bonuses
Paid time off
Paid leaves (e.g., military and parental leave)
Company
Regeneron
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
H1B Sponsorship
Regeneron has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (157)
2024 (128)
2023 (128)
2022 (137)
2021 (104)
2020 (122)
Funding
Current Stage
Public CompanyTotal Funding
$15.93MKey Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M
Leadership Team
Recent News
Pharmaceutical Technology
2026-01-16
2026-01-16
Company data provided by crunchbase